EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lipocalin-2, Matrix Metalloproteinase-9, and MMP-9/NGAL Complex in Upper Aerodigestive Tract Carcinomas: A Pilot Study

Luca Cavalcanti iD, Silvia Francati iD, Giampiero Ferraguti iD, Francesca Fanfarillo iD, Daniele Peluso iD, Christian Barbato iD, Antonio Greco iD, Antonio Minni, Carla Petrella iD

Cells · 2025

DOI: 10.3390/cells14070506 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Luca Cavalcanti und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Sensory Organs, Sapienza University of Rome, 00161 Roma, Italy. Hauptthemen laut MEDLINE: Lipocalin-2, Matrix Metalloproteinase 9. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sapienza University of Rome, Bandi Ateneo Sapienza Progetti Avvio alla Ricerca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Upper aerodigestive tract (UADT) carcinomas have a high and rapidly increasing incidence, particularly in industrialized countries. The identification of diagnostic and prognostic biomarkers remains a key objective in oncological research. However, conflicting data have been reported regarding Lipocalin-2 (LCN-2 or NGAL), Matrix Metalloproteinase-9 (MMP-9), and the MMP-9/NGAL complex in UADT carcinomas. For this reason, the primary aim of this study was to investigate the involvement and modulation of the LCN-2 system in UADT cancer by selecting patients at first diagnosis and excluding any pharmacological or interventional treatments that could act as confounding factors. In this clinical retrospective pilot study, we investigated LCN-2 and MMP-9 tissue gene expression, as well as circulating levels of LCN-2, MMP-9, and the MMP-9/NGAL complex. Our findings revealed a downregulation of LCN-2 and an upregulation of MMP-9 gene expression in tumor tissues compared to healthy counterparts. A similar trend was observed in circulating levels, with decreased LCN-2 and increased MMP-9 in cancer patients compared to healthy controls. Additionally, serum levels of the MMP-9/NGAL complex were significantly elevated in UADT cancer patients relative to controls. Our study suggests a potentially distinct role for the free form of LCN-2 and its conjugated form (MMP-9/NGAL complex) in UADT tumors. These findings not only provide new insights into the molecular mechanisms underlying tumor progression but also highlight the potential clinical relevance of these biomarkers. The differential expression patterns observed suggest that the LCN-2 and MMP-9/NGAL complex could serve as valuable tools for improving early diagnosis, monitoring disease progression, and potentially guiding therapeutic strategies. Further research is needed to validate their utility in clinical settings and to explore their prognostic and predictive value in personalized treatment approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lipocalin-2Matrix Metalloproteinase 9HumansPilot ProjectsMaleFemaleMiddle AgedAgedBiomarkers, TumorGene Expression Regulation, NeoplasticRetrospective StudiesAdult

Stichwörter der Autor:innen

MMP-9/NGAL complexlipocalin-2matrix metalloproteinase-9upper aerodigestive tract carcinomas

Substanzen

Lipocalin-2Matrix Metalloproteinase 9LCN2 protein, humanMMP9 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Sensory Organs, Sapienza University of Rome, 00161 Roma, Italy.
  • Department of Experimental Medicine, Sapienza University of Rome, 00161 Roma, Italy.
  • PhD School of Applied Medical-Surgical Sciences, University of Rome "Tor Vergata", Via Montpellier 1, 00133 Roma, Italy.
  • Department of Biology, University of Rome "Tor Vergata", 00133 Roma, Italy.
  • Institute of Biochemistry and Cell Biology (IBBC-CNR), 00161 Roma, Italy.
  • Division of Otolaryngology-Head and Neck Surgery, San Camillo de Lellis Hospital, ASL Rieti-Sapienza University, Viale Kennedy, 02100 Rieti, Italy.

ORCID-Profile: Luca Cavalcanti, Silvia Francati, Giampiero Ferraguti, Francesca Fanfarillo, Daniele Peluso, Christian Barbato, Antonio Greco, Carla Petrella

Förderung

  • Sapienza University of Rome
  • Bandi Ateneo Sapienza Progetti Avvio alla Ricerca

Zitieren

APA

Cavalcanti, L., Francati, S., Ferraguti, G., Fanfarillo, F., Peluso, D., Barbato, C., Greco, A., Minni, A., & Petrella, C. (2025). Lipocalin-2, Matrix Metalloproteinase-9, and MMP-9/NGAL Complex in Upper Aerodigestive Tract Carcinomas: A Pilot Study. Cells. https://doi.org/10.3390/cells14070506

Vancouver

Cavalcanti L, Francati S, Ferraguti G, Fanfarillo F, Peluso D, Barbato C, et al. Lipocalin-2, Matrix Metalloproteinase-9, and MMP-9/NGAL Complex in Upper Aerodigestive Tract Carcinomas: A Pilot Study. Cells. 2025. doi:10.3390/cells14070506

BibTeX
@article{Cavalcanti2025,
  author = {Cavalcanti, Luca and Francati, Silvia and Ferraguti, Giampiero and Fanfarillo, Francesca and Peluso, Daniele and Barbato, Christian and Greco, Antonio and Minni, Antonio and Petrella, Carla},
  title = {Lipocalin-2, Matrix Metalloproteinase-9, and MMP-9/NGAL Complex in Upper Aerodigestive Tract Carcinomas: A Pilot Study},
  journal = {Cells},
  year = {2025},
  doi = {10.3390/cells14070506}
}
Kostenlos starten →